We are live on ! Find out more
BFRA

Biofrontera AG American Depositary Shares

Delisted

BFRA was delisted on the 4th of March, 2022.

5 hedge funds and large institutions have $5.33M invested in Biofrontera AG American Depositary Shares in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% less capital invested

Capital invested by funds: $6.59M → $5.33M (-$1.26M)

29% less funds holding

Funds holding: 75 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
3
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AIC
1
AWM Investment Company
New York
$3.54M
HA
2
Heartland Advisors
Wisconsin
$1.76M +$633K +50,000 +50%
UBS Group
3
UBS Group
Switzerland
$18K +$6.07K +480 +47%
ANBT
4
American National Bank & Trust
Texas
$12K
TRCT
5
Tower Research Capital (TRC)
New York
$1K +$708 +56 +373%
OM
6
Opaleye Management
Massachusetts
-$1.07M -79,007 Closed
Deutsche Bank
7
Deutsche Bank
Germany
-$19K -1,400 Closed

BFRA Hedge Fund Activity: Q4 2018 in Review

5 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Biofrontera AG American Depositary Shares (BFRA) for Q4 2018, worth a combined $5.33M — down 19% from $6.59M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of BFRA and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 3 added.

The largest buyer was Heartland Advisors, adding an estimated $633K. The largest seller was Opaleye Management, exiting entirely with an estimated $1.07M sold.

  • 5 institutional investors held Biofrontera AG American Depositary Shares (BFRA) as of Q4 2018, down from 7 in Q3 2018.
  • Funds reported $5.33M of Biofrontera AG American Depositary Shares stock for Q4 2018, down 19% quarter-over-quarter.
  • 0 funds opened new Biofrontera AG American Depositary Shares positions in Q4 2018 and 2 closed out, a net change of -2 holders.
  • The largest Biofrontera AG American Depositary Shares buyer in Q4 2018 was Heartland Advisors, an estimated $633K added.
  • The largest Biofrontera AG American Depositary Shares seller in Q4 2018 was Opaleye Management, an estimated $1.07M sold.

Based on aggregated 13F filings for Q4 2018.